Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725504 · ClinicalTrials.gov registry record · NA
Effect of IV Lidocaine Infusions on Pain
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT00725504: Completed NA study, sponsored by Stanford University.
NCT00725504 is a NA study that has completed, run by Stanford University. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00725504, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
Our goals for this study involve using intravenous lidocaine as it is normally used in the Stanford Pain Management Center to assess the effect of intravenous lidocaine on chronic pain. Studies have been done determining the efficacy of intravenous lidocaine for treating pain but little research has been done to determine the effects of an intravenous lidocaine infusion on the different components of the pain experience. Our study will incorporate pain quality measures both before and during the infusions of lidocaine to determine changes in present pain intensity.
Interventions
- DRUG Intravenous lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00725504
The ClinicalTrials.gov registry entry for NCT00725504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous lidocaine is the first listed.
NCT00725504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00725504 about?
NCT00725504 is a clinical study titled "Effect of IV Lidocaine Infusions on Pain". Our goals for this study involve using intravenous lidocaine as it is normally used in the Stanford Pain Management Center to assess the effect of intravenous lidocaine on chronic pain. Studies have been done determining the efficacy of intravenous lidocaine for treating pain but little research has...
What is the current status of trial NCT00725504?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2008-09. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00725504?
The interventions under investigation include: Intravenous lidocaine (DRUG).
Who is sponsoring clinical trial NCT00725504?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.